These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 18335797)
21. [Autologous stem cell transplantation in multiple myeloma - contra]. Ludwig H Dtsch Med Wochenschr; 2009 Sep; 134(39):1943. PubMed ID: 19760556 [No Abstract] [Full Text] [Related]
22. Autologous stem cell transplants in Jehovah's Witnesses. Brown NM; Kim SY; Ford PA Bone Marrow Transplant; 2009 Sep; 44(6):391-2. PubMed ID: 19308040 [No Abstract] [Full Text] [Related]
23. The effect of statin use at the time of autologous transplant on response and survival in multiple myeloma. Hamadani M; Hade E; Benson DM; Hofmeister CC Biol Blood Marrow Transplant; 2008 Mar; 14(3):351-2. PubMed ID: 18275902 [No Abstract] [Full Text] [Related]
24. Posterior reversible encephalopathy syndrome as a consequence of high dose steroid administration after autologous PBSCT. Sukumaran S; George B; Nair HP; Drobyski WR Bone Marrow Transplant; 2010 Apr; 45(4):779-80. PubMed ID: 19684634 [No Abstract] [Full Text] [Related]
28. Allograft versus autograft for myeloma. Kerr C Lancet Oncol; 2007 May; 8(5):375. PubMed ID: 17514802 [No Abstract] [Full Text] [Related]
29. Perforation of the superior vena cava after subclavian catheterization: a rare complication after autologous PBSCT. Abdelkefi A; Ben Gaied O; Ladeb S; Labbène I; Torjman L; Lakhal A; Ferjani M; Ben Othman T Bone Marrow Transplant; 2009 Jun; 43(11):891-2. PubMed ID: 19104494 [No Abstract] [Full Text] [Related]
30. Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation. Malhotra P; Varma S; Varma N; Sharma RR; Jain S; Kumari S; Manoj R; Marwaha N Am J Hematol; 2005 Oct; 80(2):164-5. PubMed ID: 16184590 [No Abstract] [Full Text] [Related]
31. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival. Lahuerta JJ; Mateos MV; Martínez-López J; Rosiñol L; Sureda A; de la Rubia J; García-Laraña J; Martínez-Martínez R; Hernández-García MT; Carrera D; Besalduch J; de Arriba F; Ribera JM; Escoda L; Hernández-Ruiz B; García-Frade J; Rivas-González C; Alegre A; Bladé J; San Miguel JF J Clin Oncol; 2008 Dec; 26(35):5775-82. PubMed ID: 19001321 [TBL] [Abstract][Full Text] [Related]
32. High dose chemotherapy and autologous stem cell transplantation in patients with multiple myeloma: the experience of a single haematological unit. Papanikolaou X; Maltezas D; Repousis P; Athanassopoulos A; Alexia S; Megalakaki K; Kotsopoulou M; Mitsouli-Mentzikof C J BUON; 2008; 13(2):193-7. PubMed ID: 18555464 [TBL] [Abstract][Full Text] [Related]
33. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma. Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297 [TBL] [Abstract][Full Text] [Related]
34. [Multiple myeloma relapsed or progressed as plasmacytoma after allogeneic reduced-intensity stem cell transplantation: report of three cases]. Sugimoto Y; Nishii K; Miyata E; Fujieda A; Yamaguchi M; Masuya M; Katayama N Rinsho Ketsueki; 2009 Apr; 50(4):289-94. PubMed ID: 19404022 [TBL] [Abstract][Full Text] [Related]
35. Salvage with a mini-allograft after primary engraftment failure following autologous transplant for multiple myeloma. Subramaniam K; George B; Mathews V; Viswabandya A; Srivastava A; Chandy M Bone Marrow Transplant; 2007 Feb; 39(4):239-40. PubMed ID: 17211429 [No Abstract] [Full Text] [Related]
36. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma. Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP Cytotherapy; 2008; 10(5):507-17. PubMed ID: 18608354 [TBL] [Abstract][Full Text] [Related]
37. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705 [TBL] [Abstract][Full Text] [Related]
38. [Treatment for multiple myeloma: current status and future strategy in Japan]. Iida S Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921 [No Abstract] [Full Text] [Related]
39. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant. Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753 [TBL] [Abstract][Full Text] [Related]
40. Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling. Iacobelli S; Apperley J; Morris C Exp Hematol; 2008 Nov; 36(11):1567-71. PubMed ID: 18722040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]